Further targeted inhibition of the PERK/ATF4 pathway via VSMC-specific genetic depletion of PERK or pharmacological inhibition prevented AAA expansion and was associated with a preservation of VSMC function. This evidence concerns the gene ATF4 and triple-A syndrome.